New funding for development of mucosal vaccines based on nanoparticle technology

The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.

http://www.sciencedaily.com/releases/2013/10/131008102356.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fimmune_system+%28ScienceDaily%3A+Health+%26+Medicine+News+--+Immune+System%29